Our focus remains firmly on addressing infectious diseases of poverty, and the TDR Strategy 2024-2029 is grounded in country-led priorities. However, we recognize that this cannot be done effectively without taking into consideration the changing global context in which we work. By supporting research and strengthening research capacity, we aim to contribute to building country resilience to four major global health challenges: control and elimination of diseases of poverty, climate’s impact on health, epidemics and outbreaks, and resistance to treatment and control agents.
Highlight 1/5
Ghana approved moxidectin for the treatment of river blindness. This first-of-its-kind approval paves the way for a TDR-supported pilot implementation programme.
Highlight 2/5
New implementation research training modules have been developed featuring case studies addressing diseases such as Chagas disease and trachoma.
Highlight 3/5
The Early Warning and Response System for climate-sensitive diseases (EWARS-csd) is being piloted in three additional countries in West Africa (Burkina Faso, Nigeria and Senegal).
Highlight 4/5
We have developed and piloted a research package for conducting root cause analysis of yellow fever outbreaks in Cameroon, Central African Republic and Guinea.
Highlight 5/5
TDR-supported studies have led to national policy changes in the Dominican Republic and Ecuador, which have adopted short all-oral regimens for drug-resistant TB patients.